These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26072676)

  • 1. Novel Mechanisms for the Antifibrotic Action of Nintedanib.
    Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
    Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
    Lin X; Wen J; Liu R; Gao W; Qu B; Yu M
    Mol Vis; 2018; 24():789-800. PubMed ID: 30636861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
    Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
    FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
    Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
    Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
    Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
    Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
    Knüppel L; Ishikawa Y; Aichler M; Heinzelmann K; Hatz R; Behr J; Walch A; Bächinger HP; Eickelberg O; Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):77-90. PubMed ID: 28257580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition for disrepair in the aged lung.
    Sueblinvong V; Neujahr DC; Mills ST; Roser-Page S; Ritzenthaler JD; Guidot D; Rojas M; Roman J
    Am J Med Sci; 2012 Jul; 344(1):41-51. PubMed ID: 22173045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.